Cargando…

De novo metastatic breast cancer: Subgroup analysis of molecular subtypes and prognosis

The purpose of the present study was to analyze the clinical and pathological characteristics, treatment, and prognosis of de novo metastatic breast cancer (DnMBC). Information regarding 1,890 patients treated for advanced breast cancer at the Tianjin Medical University Cancer Hospital between Janua...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Li, Li, Zhijun, Zhang, Jie, Wu, Yansheng, Zhu, Yuying, Tong, Zhongsheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7068499/ https://www.ncbi.nlm.nih.gov/pubmed/32218843 http://dx.doi.org/10.3892/ol.2020.11359

Ejemplares similares

Comparison of the clinicopathological characteristics and prognosis between Chinese patients with breast cancer with bone-only and non-bone-only metastasis
por: Zhang, Li, et al.
Publicado: (2020)

Microcalcification and BMP-2 in breast cancer: correlation with clinicopathological features and outcomes
por: Zhang, Li, et al.
Publicado: (2019)

Molecular subtyping for clinically defined breast cancer subgroups
por: Zhao, Xi, et al.
Publicado: (2015)

Characteristics and survival of patients with metachronous or synchronous double primary malignancies: breast and thyroid cancer
por: Zhang, Li, et al.
Publicado: (2016)

Metaplastic breast cancer: Treatment and prognosis by molecular subtype
por: Hu, Jin, et al.
Publicado: (2021)

Model-based inference of metastatic seeding rates in de novo metastatic breast cancer reveals the impact of secondary seeding and molecular subtype
por: Vitos, Noemi, et al.
Publicado: (2022)

Breast Cancer Subtypes and Prognosis: Answers to Subgroup Classification Questions, Identifying the Worst Subgroup in Our Single-Center Series
por: Cosar, Rusen, et al.
Publicado: (2022)

Prognosis of metastatic breast cancer: are there differences between patients with de novo and recurrent metastatic breast cancer?
por: Lobbezoo, D J A, et al.
Publicado: (2015)

The mixed subtype has a worse prognosis than other histological subtypes: a retrospective analysis of 217 patients with metaplastic breast cancer
por: Hu, Jiayue, et al.
Publicado: (2023)

Receptor conversion impacts outcomes of different molecular subtypes of primary breast cancer
por: Zhao, Weipeng, et al.
Publicado: (2021)

Curcumin induces cell death of the main molecular myeloma subtypes, particularly the poor prognosis subgroups
por: Gomez-Bougie, Patricia, et al.
Publicado: (2014)

HBV Infection Status Does Not Influence the Initial Metastatic Pattern and the Prognosis of Breast Cancer Patients with de novo and Relapsed Metastatic Disease
por: Zhang, Ningning, et al.
Publicado: (2022)

MLSP: A bioinformatics tool for predicting molecular subtypes and prognosis in patients with breast cancer
por: Zhu, Jie, et al.
Publicado: (2022)

The metastasis patterns and their prognostic features in patients with de novo metastatic breast cancer of different ages
por: Sun, Shujuan, et al.
Publicado: (2023)

Evaluation of the pathological response and prognosis following neoadjuvant chemotherapy in molecular subtypes of breast cancer
por: Zhao, Yue, et al.
Publicado: (2015)

Prognostic Model for De Novo and Recurrent Metastatic Breast Cancer
por: Barcenas, Carlos H., et al.
Publicado: (2021)

DNA Methylation Based Molecular Subtypes Predict Prognosis in Breast Cancer Patients
por: Wu, Zeng-Hong, et al.
Publicado: (2021)

Molecular subtypes and prognosis in RCC
por: Beuselinck, Benoit, et al.
Publicado: (2015)

DNA methylation molecular subtypes for prognosis prediction in lung adenocarcinoma
por: Xu, Duoduo, et al.
Publicado: (2022)

Real-world evidence of the management and prognosis of young women (⩽40 years) with de novo metastatic breast cancer
por: Mallet, Amélie, et al.
Publicado: (2022)

SCD5 expression correlates with prognosis and response to neoadjuvant chemotherapy in breast cancer
por: Zhao, Weipeng, et al.
Publicado: (2021)

Subtype-specific risk models for accurately predicting the prognosis of breast cancer using differentially expressed autophagy-related genes
por: Han, Baoai, et al.
Publicado: (2020)

Interactions between immunity, proliferation and molecular subtype in breast cancer prognosis
por: Nagalla, Srikanth, et al.
Publicado: (2013)

Differences in the Tumor Molecular and Microenvironmental Landscape between Early (Non-Metastatic) and De Novo Metastatic Primary Luminal Breast Tumors
por: Lambrechts, Yentl, et al.
Publicado: (2023)

Serum amyloid A expression in the breast cancer tissue is associated with poor prognosis
por: Yang, Mu, et al.
Publicado: (2016)

Identifying ultrasound and clinical features of breast cancer molecular subtypes by ensemble decision
por: Zhang, Lei, et al.
Publicado: (2015)

Identification of immune subtypes and their prognosis and molecular implications in colorectal cancer
por: Sun, Yan, et al.
Publicado: (2022)

Long-term outcomes of non-metastatic breast cancer patients by molecular subtypes
por: Fendereski, Afsaneh, et al.
Publicado: (2022)

Consistency and Stability of Motor Subtype Classifications in Patients With de novo Parkinson’s Disease
por: Ren, Jingru, et al.
Publicado: (2021)

Comparison of clinical features, molecular alterations, and prognosis in morphological subgroups of lung invasive mucinous adenocarcinoma
por: Cai, Deng, et al.
Publicado: (2014)

Comparison of Three Motor Subtype Classifications in de novo Parkinson's Disease Patients
por: Ren, Jingru, et al.
Publicado: (2020)

Triple-negative breast cancer molecular subtyping and treatment progress
por: Yin, Li, et al.
Publicado: (2020)

The role of Ki-67 in the proliferation and prognosis of breast cancer molecular classification subtypes
por: Stathopoulos, George P., et al.
Publicado: (2014)

ERβ Isoforms Have Differential Clinical Significance in Breast Cancer Subtypes and Subgroups
por: Choi, Young, et al.
Publicado: (2022)

A phase Ib study of camrelizumab in combination with apatinib and fuzuloparib in patients with recurrent or metastatic triple-negative breast cancer
por: Zhang, Qingyuan, et al.
Publicado: (2022)

Locoregional therapy in de novo metastatic breast cancer. The unanswered question
por: Cardoso, Maria-Joao, et al.
Publicado: (2021)

Platelet-Related Molecular Subtype to Predict Prognosis in Hepatocellular Carcinoma
por: Zhang, Genhao
Publicado: (2022)

Loco-regional recurrence trend and prognosis in young women with breast cancer according to molecular subtypes: analysis of 1099 cases
por: Li, Yang, et al.
Publicado: (2021)

Comprehensive Analysis of Splicing Factor and Alternative Splicing Event to Construct Subtype-Specific Prognosis-Predicting Models for Breast Cancer
por: Zhang, He, et al.
Publicado: (2021)

Breast carcinoma: molecular markers and subtypes to predict patients at risk of developing metastatic disease
por: Inderhaug, CR, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_mmfcpph6kjci21t4f9ma7fknl7